Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England.
Tariq H IqbalNicholas Alexander KennedyAnjan DharWaqas AhmedRichard F PollockPublished in: Journal of medical economics (2024)
Results showed that FDI improved patient QoL and reduced direct healthcare expenditure versus FCM in patients with IBD and IDA in England.